Sotera Health Company (SHC) stock analysis
In our weekly check, Sotera Health Company is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 16 pass, warnings: 4, red flags: 3.
About Sotera Health Company
Sotera Health Company is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as SHC.
What our checks show for SHC
Red flags
- Net debt is 3.4x a year of EBITDA (debt/equity 3.1). That limits room in a downturn and raises refinancing risk.
- The stock has fallen as much as 79% from a peak. Would you have held through that?
- Beta 1.93: the stock usually moves more than the market, both up and down.
Warning signs
- Operating profit covers interest only 3.2 times: a weak year could make the payments hard.
- The gross margin fell by 1.3 points, to 54.4%: costs are rising faster than prices.
- Earnings per share fell 10.1% a year over the last 3 years.
- The stock is still below its previous peak.
Strengths
- The net margin rose by 1.6 points over 5 years, to 14.1%.
- Operating cash flow is 1.91x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 34.1% a year over the next years.
- Analysts expect the net margin to improve by 10.5 points from today's 14.1%.
- Free cash flow is 11% of revenue: cash for dividends, buybacks or growth.
- Actively traded: about 2.3 million shares a day.
Similar companies
BLLN · GRAL · CDNA · RDNT · QGEN · NEO
Questions
What grade does Sotera Health Company (SHC) have?
In our weekly check, Sotera Health Company is graded B (A to F). Of 23 checks on debt, profit, cash flow and trend: 16 pass, warnings: 4, red flags: 3. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of SHC stock?
This week's biggest flags for Sotera Health Company: High debt, Deep past fall, High beta. In total 7 of 23 checks show a warning or a red flag.
What does Sotera Health Company do?
Sotera Health Company is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as SHC.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis